Imithi yokugomela i-COVID-19 engaphezu kwezigidi ezingu-142 inikezwa kulo lonke elaseShayina

I-China isinikeze imithamo eyizigidi ezingu-102.4 yomjovo we-COVID-19 kusukela ngomhlaka-27 Mashi, kusho i-National Health Commission yaseShayina ngeSonto.

 

Ukunikezwa kwemithi yokugomela i-COVID-19 emhlabeni wonke eyenziwe yizinkampani ezingaphansi kwe-Sinopharm yaseShayina kudlule izigidi eziyi-100, kusho inkampani eyodwa ngoLwesihlanu. Amazwe nezifunda ezingamashumi amahlanu zivumile imithi yokugomela i-Sinopharm yokusetshenziswa kwezentengiselwano noma okuphuthumayo, kanti imithamo engaphezu kwezigidi ezingama-80 yale mithi yokugomela emibili inikezwe abantu abavela emazweni angaphezu kuka-190.

 

IShayina ibilokhu iqinisa uhlelo lwayo lokugoma ukuze yakhe isivikelo esibanzi sokuzivikela komzimba, kusho uWu Liangyou, iphini lomqondisi wehhovisi lokulawula izifo le-NHC. Lolu hlelo lugxile emaqenjini abalulekile, okuhlanganisa abantu abasemadolobheni amakhulu noma aphakathi nendawo, amadolobha amachweba noma izindawo ezisemngceleni, abasebenzi bamabhizinisi kahulumeni, abafundi basekolishi nabafundisi, kanye nabasebenzi bezitolo ezinkulu. Abantu abangaphezu kweminyaka engama-60 noma abanezifo ezingamahlalakhona bangathola umjovo ukuze bavikelwe egciwaneni.

 

Ngokusho kukaWu, kunikezwe imithamo yokugoma eyizigidi ezingu-6.12 ngoLwesihlanu.

 

UWang Huaqing, uchwepheshe oyinhloko wohlelo lokugoma e-Chinese Center for Disease Control and Prevention, weluleke esithangamini sabezindaba sangeSonto ukuthi umthamo wesibili kumele unikezwe amasonto amathathu kuya kwayisishiyagalombili ngemuva kokuthola umuthi wokuqala.

 

Abantu belulekwa ukuthi bathole imithamo emibili yomjovo ofanayo, kusho uWang, enezela ngokuthi wonke umuntu ofanelekela ukugonywa kufanele athole imijovo ngokushesha okukhulu ukuze akhe amasosha omzimba omhlambi.

 

Imithi yokugomela emibili yeSinopharm ibonakale isebenza kahle ezinhlotsheni ezingaphezu kwe-10 ezitholakala e-UK, eNingizimu Afrika nakwezinye izindawo, kusho uZhang Yuntao, iphini likamongameli we-China National Biotec Group, exhumene neSinopharm.

 

UZhang uthe kusenezinye izivivinyo eziqhubekayo mayelana nezinhlobo ezitholakala eBrazil naseZimbabwe. Idatha yocwaningo lwezokwelapha ezinganeni ezineminyaka engu-3 kuya kwengu-17 ihlangabezane nokulindelwe, okuphakamisa ukuthi iqembu lingafakwa ohlelweni lokugoma maduze nje, kusho uZhang.